OCTREOTIDE Side Effects

5227015-8 | Injection Site Irritation, Injection Site Pain
on Feb 01, 2007 Male patient from UNITED STATES , weighting 165.0 lb, was diagnosed with carcinoid tumour, diarrhoea and was treated with Octreotide (View Usage). Patient experienced the following unwanted or unexpected effects: injection site irritation, injection site pain. Octreotide dosage: 1000mg/ml Q6hour Inj.

4854708-4 | Anorexia, Ascites, Confusional State, Disease Progression, Dyspnoea, Nausea, Oedema Peripheral, Scrotal Oedema
Patient was taking Octreotide (View Usage). Patient had the following side effects: anorexia, ascites, confusional state, disease progression, dyspnoea, nausea (What is nausea?), oedema peripheral, scrotal oedema on Dec 14, 2005 from UNITED STATES Additional patient health information: Male patient , 49 years of age, weighting 242.5 lb, was diagnosed with hepatic neoplasm malignant and. Octreotide dosage: 200 Mcg Tid Sq. During the same period patient was treated with OCTREOTIDE LAR (20 Mg Im) (View Octreotide Lar Review and Octreotide Lar Label ). Patient was hospitalized.

4759063-6 | Confusional State, Fatigue
Adverse event was reported on Aug 30, 2005 by a Female patient taking Octreotide (View Usage) (Dosage: 10mg/day) was diagnosed with carcinoid syndrome and. Location: UNITED KINGDOM , 76 years of age, weighting 99.21 lb, After Octreotide was administered, patient had the following side effects: confusional state, fatigue.

4754347-X | Hyperkalaemia, Hyponatraemia
on Jun 24, 2002 Female patient from UNITED KINGDOM , 71 years of age, was diagnosed with fistula (What is fistula?) and was treated with Octreotide (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, hyponatraemia. Octreotide dosage: 1000mcg/day. During the same period patient was treated with MAXOLON (Unk, Prn) (View Maxolon Review and Maxolon Label ), METRONIDAZOLE (400 Mg, Tid) (View Metronidazole Review and Metronidazole Label ), IMODIUM (Unk, Prn) (View Imodium Review and Imodium Label ).


4647487-7 | Alanine Aminotransferase Increased, Antibody Test Positive, Aspartate Aminotransferase Increased, Asthenia, Bilirubin Conjugated Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Systolic Increased
on Apr 28, 2005 Female patient from UNITED STATES , 67 years of age, was treated with Octreotide (View Usage). Patient had the following side effects: alanine aminotransferase increased, antibody test positive, aspartate aminotransferase increased, asthenia, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood pressure systolic increased. Octreotide dosage: 50 Mg/hr Infusion. During the same period patient was treated with ATROVENT (View Atrovent Review and Atrovent Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), NORVASC (View Norvasc Review and Norvasc Label ), NEXIUM (View Nexium Review and Nexium Label ), IMDUR (View Imdur Review and Imdur Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4613544-4 | Nausea
Patient was taking Octreotide (View Usage). After Octreotide was administered, patient had the following side effects: nausea (What is nausea?) on Mar 18, 2005 from Additional patient health information: Male patient , 63 years of age, weighting 192.9 lb, was diagnosed with acromegaly and. Octreotide dosage: 50 Mcg Tid Sq.

4589498-6 | Cerebrovascular Accident, Migraine
Adverse event was reported on Feb 14, 2005 by a Female patient taking Octreotide (View Usage) (Dosage: 300ug/day) was diagnosed with osteoporosis (What is osteoporosis?) and. Location: , 70 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, migraine (What is migraine?). During the same period patient was treated with ALENDRONATE SODIUM (70mg/day) (View Alendronate Sodium Review and Alendronate Sodium Label ). Patient was hospitalized and became disabled.

4555388-8 | Atrioventricular Block Complete, Nodal Rhythm
on Jan 18, 2005 Male patient from , 56 years of age, was diagnosed with upper gastrointestinal haemorrhage and was treated with Octreotide (View Usage). Patient had the following side effects: atrioventricular block complete, nodal rhythm. Octreotide dosage: 0.05 Mg /1 Ml. During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), DOCUSATE SODIUM (View Docusate Sodium Review and Docusate Sodium Label ), HUMULIN R (View Humulin R Review and Humulin R Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), SORBITOL SOLN (View Sorbitol Soln Review and Sorbitol Soln Label ). Patient was hospitalized.